» Articles » PMID: 24971008

Delivery of Multipurpose Prevention Drug Combinations from Electrospun Nanofibers Using Composite Microarchitectures

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2014 Jun 28
PMID 24971008
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Electrospun drug-eluting fabrics have enormous potential for the delivery of physicochemically diverse drugs in combination by controlling the underlying material chemistry and fabric microarchitecture. However, the rationale for formulating drugs at high drug loading in the same or separate fibers is unknown but has important implications for product development and clinical applications.

Methods: Using a production-scale free-surface electrospinning instrument, we produced electrospun nanofibers with different microscale geometries for the co-delivery of tenofovir (TFV) and levonorgestrel (LNG) - two lead drug candidates for multipurpose prevention of HIV acquisition and unintended pregnancy. We investigated the in vitro drug release of TFV and LNG combinations from composites that deliver the two drugs from the same fiber (combined fibers) or from separate fibers in a stacked or interwoven architecture. For stacked composites, we also examined the role that fabric thickness has on drug-release kinetics. We also measured the cytotoxicity and antiviral activity of the drugs delivered alone and in combination.

Results: Herein, we report on the solution and processing parameters for the free-surface electrospinning of medical fabrics with controlled microarchitecture and high drug loading (up to 20 wt%). We observed that in vitro release of the highly water-soluble TFV, but not the water-insoluble LNG, was affected by composite microarchitecture, fabric thickness, and drug content. Finally, we showed that the drug-loaded nanofibers are noncytotoxic and that the antiviral activity of TFV is preserved through the electrospinning process and when combined with LNG.

Conclusion: Electrospun fabrics with high drug loading create multicomponent systems that benefit from the independent control of the nanofibrous microarchitecture. Our findings are significant because they will inform the design and production of composite electrospun fabrics for the co-delivery of physicochemically diverse drugs that may be useful for multipurpose prevention.

Citing Articles

Multi-material electrospinning: from methods to biomedical applications.

Xing J, Zhang M, Liu X, Wang C, Xu N, Xing D Mater Today Bio. 2023; 21:100710.

PMID: 37545561 PMC: 10401296. DOI: 10.1016/j.mtbio.2023.100710.


Electrospun collagen core/poly-l-lactic acid shell nanofibers for prolonged release of hydrophilic drug.

Huang W, Hibino T, Suye S, Fujita S RSC Adv. 2022; 11(10):5703-5711.

PMID: 35423091 PMC: 8694765. DOI: 10.1039/d0ra08353d.


Perspectives on Existing and Novel Alternative Intravaginal Probiotic Delivery Methods in the Context of Bacterial Vaginosis Infection.

Chandrashekhar P, Minooei F, Arreguin W, Masigol M, Steinbach-Rankins J AAPS J. 2021; 23(3):66.

PMID: 33973067 PMC: 8356663. DOI: 10.1208/s12248-021-00602-z.


Effect of tissue microenvironment on fibrous capsule formation to biomaterial-coated implants.

Hernandez J, Park J, Yao S, Blakney A, Nguyen H, Katz B Biomaterials. 2021; 273:120806.

PMID: 33905960 PMC: 8135119. DOI: 10.1016/j.biomaterials.2021.120806.


In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.

Minooei F, Fried J, Fuqua J, Palmer K, Steinbach-Rankins J Int J Nanomedicine. 2021; 16:1189-1206.

PMID: 33623382 PMC: 7894819. DOI: 10.2147/IJN.S287310.


References
1.
Chen D, Liao J, Liu S, Chan E . Novel biodegradable sandwich-structured nanofibrous drug-eluting membranes for repair of infected wounds: an in vitro and in vivo study. Int J Nanomedicine. 2012; 7:763-71. PMC: 3282614. DOI: 10.2147/IJN.S29119. View

2.
De Clercq E . Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge. Biochem Pharmacol. 2006; 73(7):911-22. DOI: 10.1016/j.bcp.2006.09.014. View

3.
Mayer L, Janoff A . Optimizing combination chemotherapy by controlling drug ratios. Mol Interv. 2007; 7(4):216-23. DOI: 10.1124/mi.7.4.8. View

4.
Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T . Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 2005; 436(7050):568-72. DOI: 10.1038/nature03794. View

5.
Huang C, Soenen S, Van Gulck E, Vanham G, Rejman J, Van Calenbergh S . Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery. Biomaterials. 2011; 33(3):962-9. DOI: 10.1016/j.biomaterials.2011.10.004. View